Dr Nathaly Samy | Senior Vice President - Clinical Development
Bavarian Nordic

Dr Nathaly Samy, Senior Vice President - Clinical Development, Bavarian Nordic

Dr. Samy obtained her medical and doctor’s degree from the University of Munich in Germany. Since 1995, she held several positions of increasing responsibility in the pharmaceutical and biotech industry, particularly in the field of vaccines and cancer immunotherapy. Starting her career at SmithKline Beecham, she later worked at Bavarian Nordic, Berna Biotech and Micromet before joining Bavarian Nordic again in 2007, where she is now responsible for clinical development of the Company’s infectious disease programs.  Dr. Samy has long-standing experience in building up and leading clinical departments, and in the strategic planning and worldwide execution of clinical development programs, ranging from Phase I to licensure. 


Day One 10th Oct Human, Vet, Immune @ 15:45

Update on the development of the recombinant RSV vaccine candidate MVA-BN® RSV

back to speakers